SBI Life Insurance Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SBILIFE, BSE:540719 SBI Life Insurance Company Ltd.

SBI Life Insurance Company Ltd.

06 Feb 2020

1839.90

-0.96%

SBI Life Insurance Ltd: Financials - Insurance

Buy: SBI Life Insurance Company...

Karvy

Protection Guaranteed and Annuity Protection is Paving Way to Protection Segment Rise: Value of new business APE has increased

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

SBI Life Insurance Company Ltd.

04 Feb 2020

1839.90

-0.96%

SBI LIFE INSURANCE COMPANY LIMITED

Buy: SBI Life Insurance Company...

Target

Geojit BNP Paribas

Yet another strong quarter for insurance giant SBI Life Insurance Company Limited, is a joint venture between SBI and BNP Paribas formed in 2001, which offers individual and group insurance plans, including traditional and unit linked plans. Its products cover life, health,...

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

31 Jan 2020

1839.90

-0.96%

Company Report:SBI Life Insuran

Buy: SBI Life Insurance Company...

Target

Axis Direct

SBI Life Insurance (SBILIFE) among private life insurers possesses by far the largest bancassurance network, bancassurance network size being most critical for scalability. Its individual agency force is highly productive among key private sector life insurer peers leading to cost efficiencies.

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

23 Jan 2020, 12:00AM

1839.90

-0.96%

SBI Life Insurance Co. Ltd

Buy: SBI Life Insurance Company...

ICICI Securities Limited

AUM growth remained healthy at 22% YoY to | 164190 crore. Income from investment surged at | 4073 crore in Q3FY20, leading to higher trajectory in topline. Operating expenses (commission and opex related to insurance business) grew 23.8% YoY in Q3FY20 to | 1097 crore. Led by robust...

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

22 Jan 2020, 10:20PM

1839.90

-0.96%

SBI Life Insurance (3QFY20): Margin sustains despite adverse product mix. Maintain BUY

Buy: SBI Life Insurance Company...

HDFC Securities

Given the strong distribution footprint of its parent SBI (24k+ branches), improving protection share (9MFY20: 8.0%, +174bps YoY), lowest operating cost ratios (9.1%), and improving margins (VNBM: 20.5%) we expect SBILIFE to deliver strong FY19-22E VNB CAGR of 23.3% p.a. and RoEVs of ~18-18.5%. Lower than expected growth and protection share remain a key risk to our call. SBILIFEs 3QFY20 performance was a mixed bag, as NBP/APE growth was strong at 26.8/16.3% YoY; however decline in protection/NPAR share to 6.8/5.7% (-27/-573bps QoQ) was disappointing. Strong 9MFY20 adj. VNBM at 20.5% (+30bps vs. 1HFY20) compensated. SBILIFE is our top BUY with a TP of Rs 1,230 (Dec-20 EV + 25.4x Mar-22E VNB).

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

SBI Life Insurance Company Ltd.

11 Jan 2020

1839.90

-0.96%

Insurance/AMC/Broking Tracker: 3QFY20: Pvt. Sector Ind. NBP/APE grows 18.8/16.3% YoY

Buy: SBI Life Insurance Company...

HDFC Securities

Broking While competitive intensity remains intense, the quarter witnessed default by Karvy stock broking resulting in SEBI action of debarring the broker to add clients and restricting client trades. This has resulted in risk aversion with retail investors fleeing Karvy for other larger retail brokers. We expect this trend to continue for 1-2 quarters and be beneficial for bank owned brokers. Life insurance and mutual funds Pvt. life insurers continued to grow in 3QFY20, with individual NBP/APE growth of 18.8/16.3% in 3QFY20. On the other hand, equity (ex arbitrage and ETF) flows for 3QFY20 were muted at Rs 26bn (-90.8% YoY).

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

SBI Life Insurance Company Ltd.

24 Dec 2019

1839.90

-0.96%

SBI Life (Update): Higher Growth Leads to Earnings Upgrade. Maintain BUY

Buy: SBI Life Insurance Company...

Target

HDFC Securities

Retain BUY with an increased TP of Rs 1,230 (+23.4%) implying a DCF derived Dec-20E EV + 25.4x FY22E VNB. SBILIFE continues to be our top pick in the life insurance space. Retain BUY with an increased TP of Rs 1,230 (+23.4%) implying a DCF derived Dec-20E EV + 25.4x FY22E VNB. SBILIFE continues to be our top pick in the life insurance space. Our recent interaction with SBILIFE convinced us that growth surprises will persist. Increasing width (and depth) at activating SBIs branch network and SBILIFEs new partner addition initiatives drive our conviction. Further, a higher than expected APE growth in 8MFY20, leads us to upgrade FY20E-22E APE by 3.4-7.2%.

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

21 Oct 2019

1839.90

-0.96%

SBI LIFE INSURANCE COMPANY LIMITED

Buy: SBI Life Insurance Company...

Target

Geojit BNP Paribas

SBI Life Insurance Company Limited, is a joint venture between SBI and BNP Paribas formed in 2001, which offers individual and group insurance plans, including traditional and unit linked plans. Its products cover life, health,...

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

16 Oct 2019

1839.90

-0.96%

SBI Life Insurance (2QFY20): Business as usual. Maintain BUY

Buy: SBI Life Insurance Company...

Target

HDFC Securities

Given the strong distribution footprint of its parent SBI (24k+ branches), improving protection share (1HFY20: 8.8%, +340bps YoY), lowest operating cost ratios (10.4%), improving margins (VNBM: 20.2%) and tailwinds from financialisation of savings we expect SBILIFE to deliver strong FY19-22E VNB CAGR of 20.1% p.a. and RoEVs of ~17.3%. Lower than expected growth and protection share remain a key risk to our call. SBILIFEs 2QFY20 performance continues to be strong with NBP/APE growth of 33.8/48.3%. 1HFY20 VNBM came in at 20.2% (+40bps vs. FY19) and VNB at Rs 5.7bn (+24.6% YoY). SBILIFE is our top BUY with a TP of Rs 940 (Sep-20 EV + 21.1x Sep-21E VNB).

SBI Life Insurance Company Ltd. is trading above all available SMAs

SBI Life Insurance Company Ltd.

16 Oct 2019

1839.90

-0.96%

SBI Life Insurance Co. Ltd

Buy: SBI Life Insurance Company...

Target

ICICI Securities Limited

Income from investment was healthy YoY but dipped QoQ to | 2623 crore in Q2FY20. Led by robust premium accretion, opex ratio has dipped to 6.5% in H1FY20 vs. 7.8% in H1FY19. Healthy accretion in premium led to higher policyholder surplus at | 349 crore but higher allocation to policyholders at | 293 crore and provision of | 67 crore relates to exposure to DHFL kept earnings lower than our estimate at | 130 crore. Persistency witnessed...

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

Is SBI Life Insurance Company Ltd. worth buying?

306 Votes:

Buy 75.16%

Sell 14.05%

Hold 10.78%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf